A Real-World Cohort Study of the Risks of Kidney Failure and Death in Diabetes

Key Points Rates and risks of kidney failure versus death in diabetes have not been previously quantified across a full range of kidney function. In a large population with diabetes, risk of death exceeded kidney failure overall, but kidney failure outpaced death at eGFR <30 ml/min per 1.73 m 2 . Current risk estimates are needed to support public health and clinical strategies to monitor and improve kidney health in diabetes. Background Risks of kidney failure versus death in diabetes have not been previously quantified across a full range of kidney function. The aim of the study was to assess competing risks of kidney failure and death in a real-world cohort with diabetes. Methods Cumulative incidence (CMI) functions for kidney failure and death, stratified by baseline eGFR, were estimated for the diabetes population from electronic health record data at Providence and the University of California Los Angeles health systems. Cox proportional hazards models assessed predictors of kidney failure and death. For kidney failure, cause-specific hazards were modeled with competing risk of death. Results Among 618,739 persons with diabetes followed for a median (interquartile range) of 3.79 (1.80–6.00) years during 2013–2022, 4% ( n =24,097) developed kidney failure and 10% ( n =63,128) died. Five-year CMI of kidney failure increased from 2% (95% confidence interval, 1.4% to 1.5%) for eGFR ≥90 ml/min per 1.73 m 2 to 62% (95% confidence interval, 61.0% to 63.5%) for eGFR 15–29 ml/min per 1.73 m 2 . CMI of all-cause death was higher than kidney failure with eGFR ≥45 ml/min per 1.73 m 2 , whereas kidney failure became more common at eGFR <30 ml/min per 1.73 m 2 . Hazards of kidney failure were higher in men (reference: women), 40–59 and 60–79-year groups (reference: 18–39 years), non-White race or Hispanic or Latino/a ethnicity groups (reference: non-Hispanic White), and by noncommercial (reference: commercial) health insurance or hospitalization (yes/no) within 1 year before follow-up. Hazards of death were similar except that age ≥80 years imparted the highest risk, and only the American Indian or Alaska Native and other race groups had higher risk. Conclusions Death was more likely than kidney failure at eGFR ≥45 ml/min per 1.73 m 2 , but this trend reversed at eGFR <30 ml/min per 1.73 m 2 . These contemporary risk estimates are important for public health and clinical strategies for monitoring and interventions to improve kidney health in diabetes.

Authors

Institutions

Publication Details

Journal
Clinical Journal of the American Society of Nephrology
Published
2025-09-08
DOI
https://doi.org/10.2215/cjn.0000000857
Citations
4
Primary Topic
Neurological and metabolic disorders
Type
article
Field-Weighted Citation Impact
5.18
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Real-World Cohort Study of the Risks of Kidney Failure and Death in Diabetes

Kenn B. Daratha, Radica Z. Alicic, O. Kenrik Duru, Susanne B. Nicholas et al.
4 citations
Clinical Journal of the American Society of Nephrology
Neurological and metabolic disorders
5.18
article

A Real-World Cohort Study of the Risks of Kidney Failure and Death in Diabetes

Kenn B. Daratha, Radica Z. Alicic, O. Kenrik Duru, Susanne B. Nicholas, Lindsey M. Kornowske, Katherine R. Tuttle, Meda E. Pavkov, Keith C. Norris, Cami R. Jones, Joshua J. Neumiller, Christina Reynolds
article en
4 citations

Abstract

Key Points Rates and risks of kidney failure versus death in diabetes have not been previously quantified across a full range of kidney function. In a large population with diabetes, risk of death exceeded kidney failure overall, but kidney failure outpaced death at eGFR <30 ml/min per 1.73 m 2 . Current risk estimates are needed to support public health and clinical strategies to monitor and improve kidney health in diabetes. Background Risks of kidney failure versus death in diabetes have not been previously quantified across a full range of kidney function. The aim of the study was to assess competing risks of kidney failure and death in a real-world cohort with diabetes. Methods Cumulative incidence (CMI) functions for kidney failure and death, stratified by baseline eGFR, were estimated for the diabetes population from electronic health record data at Providence and the University of California Los Angeles health systems. Cox proportional hazards models assessed predictors of kidney failure and death. For kidney failure, cause-specific hazards were modeled with competing risk of death. Results Among 618,739 persons with diabetes followed for a median (interquartile range) of 3.79 (1.80–6.00) years during 2013–2022, 4% ( n =24,097) developed kidney failure and 10% ( n =63,128) died. Five-year CMI of kidney failure increased from 2% (95% confidence interval, 1.4% to 1.5%) for eGFR ≥90 ml/min per 1.73 m 2 to 62% (95% confidence interval, 61.0% to 63.5%) for eGFR 15–29 ml/min per 1.73 m 2 . CMI of all-cause death was higher than kidney failure with eGFR ≥45 ml/min per 1.73 m 2 , whereas kidney failure became more common at eGFR <30 ml/min per 1.73 m 2 . Hazards of kidney failure were higher in men (reference: women), 40–59 and 60–79-year groups (reference: 18–39 years), non-White race or Hispanic or Latino/a ethnicity groups (reference: non-Hispanic White), and by noncommercial (reference: commercial) health insurance or hospitalization (yes/no) within 1 year before follow-up. Hazards of death were similar except that age ≥80 years imparted the highest risk, and only the American Indian or Alaska Native and other race groups had higher risk. Conclusions Death was more likely than kidney failure at eGFR ≥45 ml/min per 1.73 m 2 , but this trend reversed at eGFR <30 ml/min per 1.73 m 2 . These contemporary risk estimates are important for public health and clinical strategies for monitoring and interventions to improve kidney health in diabetes.

Clinical Journal of the American Society of NephrologyVol. 21(1)
Centers for Disease Control and Prevention (US), Northwest Kidney Centers (US), University of California, Los Angeles (US), Washington State University Spokane (US), Providence College (US), University of Washington (US), Kidney Research UK (GB), Inland Northwest Health Services (US), Health First (US)
Openalex Percentile: Top 4%
Neurological and metabolic disorders
5.18
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.